Home ›
Trademark Categories ›
Pharmaceuticals ›
2018 ›
RE ›
REJUVIQ
Trademark search for:
REJUVIQ
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2018-01-23 — Application filed
2018-01-26 — Application filed
2018-02-02 — Application filed
2018-03-24 — Assigned to examiner
2018-03-25 — Final disposition recorded
2018-03-25 — Final disposition recorded
2018-03-25 — Final disposition recorded
2018-06-07 — Office action issued
2018-06-07 — Correspondence received in law office
2018-06-08 — Teas/email correspondence entered
2018-06-23 — Approved for pub - principal register
2018-07-09 — Assigned to lie
2018-07-25 — Notification of notice of publication e-mailed
2018-08-14 — Published for opposition
2018-08-14 — Official gazette publication confirmation e-mailed
2018-10-09 — Noa e-mailed - sou required from applicant
2019-04-04 — Sou teas extension received
2019-04-04 — Sou extension 1 filed
2019-04-04 — Sou extension 1 granted
2019-04-06 — Notice of approval of extension request e-mailed
2019-10-04 — Sou teas extension received
2019-10-04 — Sou extension 2 filed
2019-10-04 — Sou extension 2 granted
2019-10-08 — Notice of approval of extension request e-mailed
2020-04-06 — Sou teas extension received
2020-04-06 — Sou extension 3 filed
2020-04-06 — Sou extension 3 granted
2020-04-08 — Notice of approval of extension request e-mailed
2020-10-01 — Sou teas extension received
2020-10-01 — Sou extension 4 filed
2020-10-01 — Sou extension 4 granted
2020-10-03 — Notice of approval of extension request e-mailed
2021-05-10 — Application abandoned
2021-05-10 — Application abandoned
2021-05-10 — Final status recorded
Owner Information
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc.
Correspondent
Laurence Rickles TEVA PHARMACEUTICALS USA, INC.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
